1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) is sponsored by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). NIH has congressionally mandated set-aside programs for U. S.
small businesses to engage in research and development activities that have strong potential for commercialization, particularly in training and workforce development within biomedical and behavioral sciences.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) | National Institute of General Medical Sciences NIH has congressionally mandated set-aside programs for U.S. small businesses to engage in research and development activities that have strong potential for commercialization. Awards are intended to: Stimulate technological innovation.
Use small business to meet federal research and development needs. Increase private sector commercialization of innovations derived from federal research and development. Foster and encourage participation of individuals underrepresented in the biomedical research workforce in technological innovation.
The NIH SBIR/STTR program consists of two phases: Phase 1 (R41/R43) establishes the scientific and technical merit and feasibility as well as the potential for commercialization of the proposed research. Phase 2 (R42/R44) grant continues research or research and development (R&D) efforts initiated in Phase 1.
Training and Workforce Development Guidance The goal of NIGMS is to support innovative projects that could benefit the research communities related to its mission.
The Division of Training and Workforce Development supports the development of technologies and tools to enhance the research skills of post-high school individuals in the biomedical research workforce pathway or to increase the efficiencies of NIGMS research training programs.
The technologies may be new products or adaptations of existing products designed to be more efficient, cost-effective, culturally appropriate, and/or user-friendly in promoting the development of the biomedical research workforce. Examples for skills development projects include but are not limited to web-based resources, instructional software, interactive media, research-focused curriculum materials, and active learning toolkits.
Projects aimed at enhancing NIGMS training programs include but are not limited to technologies to track career outcomes of students and trainees and/or assist in the evaluation of workforce development programs (e.g., survey instruments and/or training activity tracking systems).
NIGMS does participate in the Commercialization Readiness Pilot (CRP) program designed to facilitate the transition of previously funded SBIR and STTR Phase 2 and Phase 2B projects to the commercialization stage by providing additional support for technical assistance. For information about the Training and Workforce Development NIGMS SBIR programs, e-mail Sailaja Koduri, Ph. D.
For information about NIGMS SBIR/STTR grants administration and management, email NIGMS_GAB_SBIR@nigms. nih. gov .
This page last updated on
According to the current listing, eligibility includes: U. S. small businesses that engage in research and development activities. Confirm the full requirements in the official notice before applying.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) is funded by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read articleAfter an authorization lapse froze new SBIR/STTR awards for five months, NIH reopens its submission window on August 5, 2026, with a first standard deadline of September 8. Phase I awards run to $323,090, Phase II to $2,153,927, with published waiver topics reaching $700,000 and $3 million — and a new Phase IIB Strategic Breakthrough lane up to $30 million. Here is how the restarted omnibus is structured, why applying early matters more than usual this cycle, and how to position a life-science startup to win.
Read article